Table 4

Pharmacokinetic variables

Variable (mean ± S.D.)N-PP4-aN-DN-DN-DP4-b
Injection siteGlutealGlutealGlutealDeltoid
Injection volume (ml)  4  4  1  1
Dose (mg)100100100100
Number of patients  7  6  5  5
Time of peak (days)
 Empirical1.0  ± 0.95.0  ± 3.22.4  ± 1.53.6  ± 2.3.022
 Fitted1.1  ± 0.11.8  ± 0.31.6  ± 0.21.5  ± 0.2<.001
Peak concentration (nM)
 Empirical30.9  ± 5.813.5  ± 5.015.8  ± 2.812.4  ± 5.5<.001
 Fitted32.5  ± 2.512.7  ± 1.116.1  ± 1.08.4  ± 0.5<.001
Mean residence time (days)
 Empirical4.5  ± 0.710.1  ± 1.510.0  ± 1.211.4  ± 1.1<.001
 Fitted3.1  ± 0.29.5  ± 0.710.6  ± 0.916.9  ± 1.3<.001
Half-time (days)
 Absorption2.4  ± 0.17.0  ± 0.47.7  ± 0.612.0  ± 0.9<.001
 Clearance0.25  ± 0.050.42  ± 0.110.34  ± 0.060.25  ± 0.05.002
Duration ≥5 nM (days)5.1  ± 2.09.4  ± 1.113.3  ± 2.99.0  ± 5.1.002
Clearance (liters/day)1359  ± 1491355  ± 951041  ± 591421  ± 57<.001
Area under the curve (nmol · day/liter)
 Empirical155  ± 21144  ± 30193  ± 29162  ± 34.065
 Fitted181  ± 20172  ± 12224  ± 13164  ± 7<.001
  • 4-a Esters are nandrolone decanoate (N-D) and nandrolone phenylpropionate (N-PP).

  • 4-b From analysis of variance.